BRIEF-Medicare advisory panel, in vote, expresses skepticism of brain-plaque imaging

Wed Jan 30, 2013 2:55pm EST

Related Topics

Jan 30 (Reuters) - Eli Lilly and Co : * Medicare advisory panel, in vote, expresses skepticism brain-plaque imaging

can change health outcomes in patients with early cognitive problems * Three members of medical advisory panel vote "low" confidence there is

adequate evidence PET imaging of brain beta amyloid changes health outcomes * Five panel members vote low-to-intermediate confidence imaging technique can

affect patient outcomes * Three panel members vote intermediate confidence imaging technique can affect

patient outcomes * One member of medical advisory panel votes higher confidence

imaging technique can affect patient outcomes * Panel members reviewing imaging technique involving PET scans of Eli lilly's

Amyvid imaging agent to detect brain plaque

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.